Eldad Melamed

19.4k total citations · 4 hit papers
228 papers, 13.6k citations indexed

About

Eldad Melamed is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Eldad Melamed has authored 228 papers receiving a total of 13.6k indexed citations (citations by other indexed papers that have themselves been cited), including 127 papers in Neurology, 103 papers in Cellular and Molecular Neuroscience and 58 papers in Molecular Biology. Recurrent topics in Eldad Melamed's work include Parkinson's Disease Mechanisms and Treatments (93 papers), Neurological disorders and treatments (55 papers) and Neuroscience and Neuropharmacology Research (40 papers). Eldad Melamed is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (93 papers), Neurological disorders and treatments (55 papers) and Neuroscience and Neuropharmacology Research (40 papers). Eldad Melamed collaborates with scholars based in Israel, United States and France. Eldad Melamed's co-authors include Daniel Offen, Yossi Gilgun‐Sherki, Ruth Djaldetti, Franz Hefti, Ilan Ziv, Richard J. Wurtman, Ari Barzilai, Nirit Lev, Yael Barhum and Werner Poewe and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Eldad Melamed

227 papers receiving 13.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier

2001 695 citations Yossi Gilgun‐Sherki, Eldad Melamed et al. profile →
A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease

2009 587 citations C. Warren Olanow, Olivier Rascol et al. New England Journal of Medicine profile →
The role of oxidative stress in the pathogenesis of multiple sclerosis: The need for effective antioxidant therapy

2004 513 citations Daniel Offen, Yossi Gilgun‐Sherki et al. profile →
Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization

1980 439 citations Eldad Melamed et al. Brain Research profile →

Peers

Countries citing papers authored by Eldad Melamed

Since Specialization

Citations

This map shows the geographic impact of Eldad Melamed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eldad Melamed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eldad Melamed more than expected).

Fields of papers citing papers by Eldad Melamed

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eldad Melamed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eldad Melamed. The network helps show where Eldad Melamed may publish in the future.

Co-authorship network of co-authors of Eldad Melamed

This figure shows the co-authorship network connecting the top 25 collaborators of Eldad Melamed. A scholar is included among the top collaborators of Eldad Melamed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eldad Melamed. Eldad Melamed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reduction in Regional Cerebral Blood Flow during Normal Aging Is Not Limited to Elderly Subjects1 2015 ·Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences ·Mordecai Y.‐T. Globus, Gerald R. Cooper, Eldad Melamed	0
2	Perspective: Identification of genetic variants associated with dopaminergic compensatory mechanisms in early Parkinson's disease 2013 ·Frontiers in Neuroscience ·Lior Greenbaum, Mordechai Lorberboym, Eldad Melamed, Amihai Rigbi, Yael Barhum, Yoav Kohn, (unknown), Bernard Lerer, Ruth Djaldetti	15
3	Stem cell grafting in parkinsonism – Why, how and when 2013 ·Parkinsonism & Related Disorders ·(unknown), Eldad Melamed, Erik Ch. Wolters	20
4	Differentiated Mesenchymal Stem Cells for Sciatic Nerve Injury 2011 ·Stem Cell Reviews and Reports ·(unknown), Ofer Sadan, (unknown), Eldad Melamed, Daniel Offen	54
5	The “Dying-Back” Phenomenon of Motor Neurons in ALS 2010 ·Journal of Molecular Neuroscience ·(unknown), Eldad Melamed, Daniel Offen	291
6	Unilateral lower limb rest tremor is not necessarily a presenting symptom of Parkinson's disease 2010 ·Movement Disorders ·Mark A. Hellmann, Eldad Melamed, Adam Steinmetz, Ruth Djaldetti	10
7	Comparative characterization of bone marrow-derived mesenchymal stromal cells from four different rat strains 2009 ·Cytotherapy ·Ran Barzilay, Ofer Sadan, Eldad Melamed, Daniel Offen	30
8	Validation of the freezing of gait questionnaire in patients with Parkinson's disease 2009 ·Movement Disorders ·Nir Giladi, Joseph Tal, (unknown), Oliver Rascol, David J. Brooks, Eldad Melamed, Wolfgang H. Oertel, Werner Poewe, Fabrizio Stocchi, Eduardo Tolosa	332
9	A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease breakdown → 2009 ·New England Journal of Medicine ·C. Warren Olanow, Olivier Rascol, Robert A. Hauser, Paul D. Feigin, Joseph Jankovic, Anthony E. Lang, William Langston, Eldad Melamed, Werner Poewe, Fabrizio Stocchi, Eduardo Tolosa	587
10	Lentiviral Delivery of LMX1a Enhances Dopaminergic Phenotype in Differentiated Human Bone Marrow Mesenchymal Stem Cells 2008 ·Stem Cells and Development ·Ran Barzilay, Tali Ben‐Zur, Shlomo Bulvik, Eldad Melamed, Daniel Offen	46
11	Handedness as a predictor of side of onset of Parkinson's disease 2008 ·Parkinsonism & Related Disorders ·Shlomit Yust‐Katz, (unknown), (unknown), Eldad Melamed, Ruth Djaldetti	55
12	Parkinson's disease and related disorders 2007 ·Elsevier eBooks ·William C. Koller, Eldad Melamed	1
13	The Etiopathogenesis of Parkinson Disease and Suggestions for Future Research. Part I 2007 ·Journal of Neuropathology & Experimental Neurology ·Irene Litvan, Glenda M. Halliday, Mark Hallett, Christopher G. Goetz, Walter A. Rocca, Charles Duyckaerts, Yoav Ben‐Shlomo, Dennis W. Dickson, Anthony E. Lang, Marie‐Françoise Chesselet, Maurice B. Hallett, Donato A. Di Monte, Thomas Gasser, Theo Hagg, John Hardy, (unknown), Eldad Melamed, Richard H. Myers, (unknown), (unknown)	95
14	Human Mesenchymal Stem Cells Express Neural Genes, Suggesting a Neural Predisposition 2006 ·Stem Cells and Development ·(unknown), Yossef S. Levy, Tali Ben‐Zur, (unknown), (unknown), (unknown), (unknown), (unknown), Yael Barhum, Shlomo Bulvik, Eldad Melamed, Daniel Offen	135
15	Erythropoietin delays disease onset in an amyotrophic lateral sclerosis model 2006 ·Experimental Neurology ·(unknown), Yael Barhum, (unknown), (unknown), Eldad Melamed, Daniel Offen	35
16	Protective effect of insulin-like-growth-factor-1 against dopamine-induced neurotoxicity in human and rodent neuronal cultures: possible implications for Parkinson’s disease 2001 ·Neuroscience Letters ·Daniel Offen, Biana Shtaif, (unknown), Abraham Weizman, Eldad Melamed, Irit Gil‐Ad	94
17	Mice Overexpressing Bcl-2 in Their Neurons Are Resistant to Myelin Oligodendrocyte Glycoprotein (MOG)-Induced Experimental Autoimmune Encephalomyelitis (EAE) 2000 ·Journal of Molecular Neuroscience ·Daniel Offen, (unknown), Ora Bernard, Doron Merims, (unknown), Hana Panet, Eldad Melamed, Avraham Ben‐Nun	24
18	Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease1This manuscript is based on a poster presented at the Brain Research Interactive Symposium on “Neuropeptides at the Millennium”, Miami, October 1999.1 2000 ·Brain Research ·Daniel Offen, Yossi Gilgun‐Sherki, Eldad Melamed, Mati Fridkin, Douglas E. Brenneman, Illana Gozes	126
19	The Involvement of p53 in Dopamine-Induced Apoptosis of Cerebellar Granule Neurons and Leukemic Cells Overexpressing p53 1999 ·Cellular and Molecular Neurobiology ·(unknown), Ari Barzilai, Daniel Offen, Ariel Kamsler, Eldad Melamed, (unknown)	42
20	Levodopa induces apoptosis in cultured neuronal cells—A possible accelerator of nigrostriatal degeneration in Parkinson's disease? 1997 ·Movement Disorders ·Ilan Ziv, Rina Zilkha‐Falb, Daniel Offen, Anat Shirvan, Ari Barzilai, Eldad Melamed	79

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact